Modulation of oral transmucosal permeability: Permeation enhancers

Drug Delivery to the Oral Cavity: Molecules to Market

Volumn , Issue , 2005, Pages 67-88

  Jasti, Bhaskara R ^a   Marasanapalle, Venugopal ^a   Li, Xiaoling ^a  

^a UNIVERSITY OF THE PACIFIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79551521187     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (38)

1. Aungst, J.B., and Rogers, J.N. (1994). Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery. Int. J. Pharm., 53, 227-235.
2. Birudaraj, R. (2001). Transbuccal Drug Delivery: In Vitro Characterization of Transport Pathway of Buspirone and Bioadhesive Drug Delivery System. University of the Pacific, Stockton, CA.
3. Bodde, H.E., de Vries, M.E., and Junginger, E.H. (1990). Mucoadhesive polymers for the buccal delivery of peptides, structure-adhesiveness relationships. J. Control. Release, 13, 225-231.
4. Burkitt, G.H., Young, B., and Heath, J.W. (1993). Wheater’s Functional Histology (3d ed.). Edinburgh: Churchill Livingstone.
5. Chen, H.L., Chetty, J.D., and Chien, W.Y. (1999). A mechanistic analysis to characterize oral mucosal permeation properties. Int. J. Pharm., 184, 63-72.
6. de Vries, M.E., Bodde, H.E., Verhoef, J.C., and Junginger, H.E. (1991). Developments in buccal drug delivery. Crit. Rev. Ther. Drug Carrier Syst., 8(3), 271-303.
7. Duchateau, G.S.M.J.E., Zuidema, J., and Merkus, F.W.H.M. (1986). Bile salts and intranasal drug absorption. Int. J. Pharm., 31, 193-197.
8. Gandhi, B.R., and Robinson, J.R. (1988). Bioadhesion in drug delivery. Ind. J. Pharm. Sci., 50, 145-152.
9. Gandhi, B.R., and Robinson, R.J. (1994). Oral cavity as a site for bioadhesive drug delivery. Adv. Drug Deliv. Rev., 13, 43-74.
10. Ganem-Quintanar, A., Quintanar-Guerrero, D., Falson-Rieg, F., and Buri, P. (1998). Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int. J. Pharm., 173, 203-210.
11. Gordon, G.S., Moses, A.C., Silver, R.D., Flier, J.S., and Care, M.C. (1985). Nasal absorption of insulin: Enhancement by hydrophobic bile salts. Proc. Nat. Acad. Sci., USA., 82, 7419.
12. Gumbiner, B., and Simons, K. (1986). A functional assay for proteins involved in establishing an epithelial occluding barrier: Identification of a uvomorulin-like polypeptide. J. Cell Biol., 102(2), 457-468.
13. Harris, D., and Robinson, J.R. (1990). Bioadhesive polymers in peptide drug delivery. Biomaterials, 11(9), 652-658.
14. Harris, D., and Robinson, J.R. (1992). Drug delivery via the mucous membranes of the oral cavity. J. Pharm. Sci., 81, 1-10.
15. Hoogstraate, A.J., Verhoef, J.C., Pijpers, A., van Leengoed, L.A.M.G., Verheijden, J.H.M., Junginger, H.E., and Bodde, E.H., (1996a). In vivo buccal delivery of the peptide drug buserelin with glycodeoxycholate as an absorption enhancer in pigs. Pharm. Res., 13(8), 1233-1237.
16. Hoogstraate, J.A., Senel, S., Cullander, C., Verhoef, J., Junginger, E.H., and Bodde, H.E. (1996b). Effects of bile salts on transport rates and routes of FITC-labeled compounds across porcine buccal epithelium in vitro. J. Control. Release, 40(211-221).
17. Jasti, R.B., Zhou, S., Mehta, C.R., and Li, X. (2000). Permeability of antisense oligonucleotides through procine buccal mucosa. Int. J. Pharm., 208, 35-39.
18. Lee, L.H.V., and Yamamoto, A. (1990). Penetration and enzymatic to peptide and protein absorption. Adv. Drug Delivery Rev., 4, 171-207.
19. Li, X., Zhou, S., Mehta, R.C., and Jasti, B.R. (1997). Buccal permeation of a model antisense oligonucleotide. Int’l. Sym. Contr. Rel. Bioact. Mater., 24, 667-668.
20. Morgan, R.P. (2000). Oral histology and oral pathology. Http://Www.Kcl.Ac.Uk/Ip/Peterrmorgan/Oral_Mucosa.Html. Retrieved, from the World Wide Web.
21. Nakada, Y., Awata, N., Nakamichi, C., and Sugimoto, I. (1988). The effects of additives on the oral mucosal absorption of human calcitonin in rats. J. Pharmacobio-Dyn., 11(395-401).
22. Oh, C.K., and Ritschel, A.W. (1990). Absorption characteristics of insulin through the buccal mucosa, Methods Find. Exp. Clin. Pharmacol., 12, 275-279.
23. O’Hagan, D.T., and Illum, L. (1990). Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. Crit. Rev. Ther. Drug Carrier Syst., 7(1), 35-97.
24. Portero, A., Remunan-Lopez, C., and Nielsen, H.M. (2002). The potential of chitosan in enhancing peptide and protein absorption across the Tr146 cell culture model-an in vitro model of the buccal epithelium. Pharm. Res., 19(2), 169-174.
25. Rathbone, J.M., and Hadgraft, J. (1991). Absorption of drugs from the human oral cavity. Int. J. Pharm., 74, 9-24.
26. Senel, S., Duchene, D., Hincal, A.A., Capan, Y., and Ponchel, G. (1998). In vitro studies on enhancing effect of sodium glycocholate on transbuccal permeation of morphine hydrochloride. J. Control. Release, 51(2-3), 107-113.
27. Senel, S., and Hincal, A.A. (2001). Drug permeation enhancement via buccal route:Possibilities and limitations. J. Control. Release, 72(1-3), 133-144.
28. Senel, S., Kremer, J.M., Kas, S.H., Wertz, W.P., Hincal, A.A., and Squier, A.C. (2000). Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials, 21, 2067-2071.
29. Shojaei, A. (1998). Buccal mucosa as a route for systemic drug delivery: A review. J. Pharm. Pharmaceut. Sci., 1, 15-30.
30. Shojaei, A.H., Berner, B., and Li, X. (1998). Transbuccal delivery of acyclovir (I): In vitro determination of routes of buccal transport. Pharm. Res., 15(8), 1182-1188.
31. Squier, C.A. (1991). The permeability of oral mucosa. Crit. Rev. Oral Biol. Med., 2(1), 13-32.
32. Thorsteinn, and O’Fee, R. (2002). Cyclodextrin-based drug delivery. Business Briefing. Pharmatech.
33. Veuillez, F., Kalia, Y.N., Jacques, Y., Deshusses, J., and Buri, P. (2001). Factors and strategies for improving buccal absorption of peptides. Eur. J. Pharm. Biopharm., 51(2), 93-109.
34. Washington, N., Washington, C., and Wilson, C. (2001a). Physiological Pharmaceutics-Barriers to Drug Absorption (2d ed.), New York: Taylor and Francis.
35. Washington, N., Washington, C., and Wilson, G.C. (2001b). Drug delivery to the oral cavity or mouth. Biological Pharmaceutics: Barriers to Drug Absorption (pp. 37-58). New York: Taylor and Francis.
36. Xiang, J., Fang, X., and Li, X. (2002). Transbuccal delivery of 2′,3′-Dideoxycytidine: In vitro permeation study and histological investigation. Int. J. Pharm. 231(1), 57-66.
37. Yamamoto, A., Hayakawa, E., Kato, Y., Nishiura, A., and Lee, V.H. (1992). A mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit. J. Pharmacol. Exp. Ther., 263(1), 25-31.
38. Zhang, H., and Robinson, R.J. (1996). Routes of Drug Transport across Oral Mucosa in Oral Mucosal Drug Delivery. New York: Marcel Dekker.